APVRS 2025 Manila

Roche

We are Roche

A healthier future drives us to innovate. Roche advances science to ensure access to the healthcare people need today and for generations to come—creating a world where we all have more time with the people we love.

About Us

Founded in 1896 in Basel, Switzerland, Roche has become a global leader in healthcare, combining pharmaceuticals and diagnostics to deliver integrated solutions. With over 125 years of expertise, Roche operates in more than 95 countries1 with nearly 103,000 employees2, all dedicated to transforming patient care.

Our strength lies in innovation. We invest heavily in research to tackle some of the most pressing health challenges, from cancer and infectious diseases to neuroscience, immunology, and ophthalmology. By linking diagnostics and medicines, we provide a holistic view of patient health, ensuring more precise, effective, and sustainable care.

Our Mission

We strive to improve lives through science. Beyond developing new therapies, we focus on prevention, early detection, and long-term management. Guided by values of sustainability, access, and ethics, Roche ensures that breakthroughs benefit patients worldwide.

Ophthalmology at Roche

Vision is essential to quality of life. Millions worldwide suffer from chronic retinal conditions such as Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)—diseases that require ongoing treatment and management.3 Roche is transforming this landscape by developing therapies that preserve sight while reducing the burden of frequent interventions.

Our ophthalmology research is focused on:

  • Exploring novel pathways and targets to improve retinal health.
  • Innovating delivery systems that lessen treatment frequency.
  • Conducting inclusive clinical trials that reflect the diversity of real-world patients.

Ophtha Innovation Challenge

Roche also invests in advancing knowledge and collaboration. The Ophtha Innovation Challenge fosters creativity and seeks new solutions to close gaps in care for patients, caregivers, and physicians—whether through better education, stronger support resources, or improved data sharing.

Our Commitment

What makes us Roche is more than science—it’s our belief that innovation must give people more time, independence, and possibilities. By transforming retinal care and developing better personalized solutions in the diagnosis, treatment and care for cancer patients and those afflicted with rare diseases, we are building a healthier future for all.

  1. Roche. Contact us. Available at https://www.roche.com/contact. Accessed 14 October 2025.
  2. Roche. Facts & Figures. Available at https://careers.roche.com/global/en. Accessed 14 October 2025.
  3. Janco L., Stefanickova J., Busanyova B., et al. Economic burden of age-related macular degeneration and diabetic macular edema in Slovakia: a cost-of-illness analysis. Bratislava Medical Journal, 126:544–551, 2025.
Important Notice: APVRS 2025 Fake or Scammer Websites and Emails

Be cautious of fake or scammer websites and emails pretending to be the official APVRS 2025 system, as these are not affiliated with us.

Please be advised that congress.2025.apvrs.org is the only official system for congress registration.

In addition, all hotel booking confirmation emails will be sent exclusively from the official APVRS email domain (@apvrs.org) or directly from the hotel. No other entities, including those claiming to be appointed travel agencies, are authorized to handle APVRS 2025 bookings.

Verify the website and sender before responding to any registration or booking-related communications. Do not disclose any personal information if you have concerns.

For assistance or inquiries, please contact the APVRS Secretariat at secretariat@apvrs.org.

Ok
Important Notice: APVRS 2025 Fake or Scammer Websites and Emails
Be cautious of fake or scammer websites and emails pretending to be the official APVRS 2025 system, as these are not affiliated with us. Please be advised that congress.2025.apvrs.org is the only official system for congress registration. In addition, all hotel booking confirmation emails will be sent exclusively from the official APVRS email domain (@apvrs.org) or directly from the hotel. No other entities, including those claiming to be appointed travel agencies, are authorized to handle APVRS 2025 bookings. Verify the website and sender before responding to any registration or booking-related communications. Do not disclose any personal information if you have concerns. For assistance or inquiries, please contact the APVRS Secretariat at secretariat@apvrs.org.